These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19469028)

  • 1. Regulated compensated donation in Pakistan and Iran.
    Rizvi AH; Naqvi AS; Zafar NM; Ahmed E
    Curr Opin Organ Transplant; 2009 Apr; 14(2):124-8. PubMed ID: 19469028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated compensation for kidney donors in the Philippines.
    Padilla BS
    Curr Opin Organ Transplant; 2009 Apr; 14(2):120-3. PubMed ID: 19469027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paid Living Donation and Growth of Deceased Donor Programs.
    Ghahramani N
    Transplantation; 2016 Jun; 100(6):1165-9. PubMed ID: 27203584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implications of Istanbul Declaration on organ trafficking and transplant tourism.
    Delmonico FL
    Curr Opin Organ Transplant; 2009 Apr; 14(2):116-9. PubMed ID: 19300258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incentives for organ donation in the United States: feasible alternative or forthcoming apocalypse?
    Hippen B; Matas A
    Curr Opin Organ Transplant; 2009 Apr; 14(2):140-6. PubMed ID: 19307965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cash, rewards, and benefits in organ transplantation: an open letter to Senator Arlen Specter.
    Danovitch G
    Curr Opin Organ Transplant; 2009 Apr; 14(2):129-33. PubMed ID: 19300257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Travel for transplantation in iran: pros and cons regarding Iranian model.
    Ossareh S; Broumand B
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():90-4. PubMed ID: 25894134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the likely harms to kidney vendors in regulated organ markets.
    Koplin J
    Am J Bioeth; 2014; 14(10):7-18. PubMed ID: 25229573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In defense of a regulated system of compensation for living donation.
    Matas AJ; Hippen B; Satel S
    Curr Opin Organ Transplant; 2008 Aug; 13(4):379-85. PubMed ID: 18685333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incentivizing living organ donation.
    Cynowiec J; Kim J; Qazi YA
    Curr Opin Organ Transplant; 2009 Apr; 14(2):201-5. PubMed ID: 19300256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of living-unrelated transplant on establishing deceased-donor liver program in Syria.
    Saeed B
    Exp Clin Transplant; 2014 Oct; 12(5):494-7. PubMed ID: 25299377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sociological and ethical issues in transplant commercialism.
    Epstein M
    Curr Opin Organ Transplant; 2009 Apr; 14(2):134-9. PubMed ID: 19307964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Iranian model of living renal transplantation.
    Mahdavi-Mazdeh M
    Kidney Int; 2012 Sep; 82(6):627-34. PubMed ID: 22673884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iranian model of paid and regulated living-unrelated kidney donation.
    Ghods AJ; Savaj S
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1136-45. PubMed ID: 17699338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prohibition of kidney sales and organ markets should remain.
    Danovitch GM; Delmonico FL
    Curr Opin Organ Transplant; 2008 Aug; 13(4):386-94. PubMed ID: 18685334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplantation from unrelated donors.
    Mor E
    Curr Opin Organ Transplant; 2009 Apr; 14(2):113-5. PubMed ID: 19276808
    [No Abstract]   [Full Text] [Related]  

  • 17. Commercial living non-related organ transplantation: a viewpoint from a developed country.
    Hoyer PF
    Pediatr Nephrol; 2006 Oct; 21(10):1364-8. PubMed ID: 16810510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paired kidney donations to expand the living donor pool.
    Ferrari P; de Klerk M
    J Nephrol; 2009; 22(6):699-707. PubMed ID: 19967648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cost-Benefit Analysis of Government Compensation of Kidney Donors.
    Held PJ; McCormick F; Ojo A; Roberts JP
    Am J Transplant; 2016 Mar; 16(3):877-85. PubMed ID: 26474298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coercion, dissatisfaction, and social stigma: an ethnographic study of compensated living kidney donation in Iran.
    Fry-Revere S; Chen D; Bastani B; Golestani S; Agarwal R; Kugathasan H; Le M
    Int Urol Nephrol; 2020 Dec; 52(12):2403-2414. PubMed ID: 29480443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.